Ensuring the safety of participants in human clinical trials is of utmost importance. Ethical guidelines and regulatory frameworks, such as those provided by the FDA and WHO, mandate informed consent, risk assessment, and continuous monitoring of participants. Institutional Review Boards (IRBs) review and approve trial protocols to safeguard participant welfare and uphold ethical standards.
